-
Je něco špatně v tomto záznamu ?
Developmental Changes in Peripherin-eGFP Expression in Spiral Ganglion Neurons
KL. Elliott, J. Kersigo, JH. Lee, I. Jahan, G. Pavlinkova, B. Fritzsch, EN. Yamoah
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2007
Free Medical Journals
od 2007
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2007-12-30 do 2021-12-31
Open Access Digital Library
od 2007-01-01
Open Access Digital Library
od 2007-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2007
- Publikační typ
- časopisecké články MeSH
The two types of spiral ganglion neurons (SGNs), types I and II, innervate inner hair cells and outer hair cells, respectively, within the mammalian cochlea and send another process back to cochlear nuclei in the hindbrain. Studying these two neuronal types has been made easier with the identification of unique molecular markers. One of these markers, peripherin, was shown using antibodies to be present in all SGNs initially but becomes specific to type II SGNs during maturation. We used mice with fluorescently labeled peripherin (Prph-eGFP) to examine peripherin expression in SGNs during development and in aged mice. Using these mice, we confirm the initial expression of Prph-eGFP in both types I and II neurons and eventual restriction to only type II perikarya shortly after birth. However, while Prph-eGFP is uniquely expressed within type II cell bodies by P8, both types I and II peripheral and central processes continue to express Prph-eGFP for some time before becoming downregulated. Only at P30 was there selective type II Prph-eGFP expression in central but not peripheral processes. By 9 months, only the type II cell bodies and more distal central processes retain Prph-eGFP expression. Our results show that Prph-eGFP is a reliable marker for type II SGN cell bodies beyond P8; however, it is not generally a suitable marker for type II processes, except for central processes beyond P30. How the changes in Prph-eGFP expression relate to subsequent protein expression remains to be explored.
Department of Biology CLAS The University of Iowa Iowa City IA United States
Department of Otolaryngology CLAS The University of Iowa Iowa City IA United States
Department of Physiology School of Medicine University of Nevada Reno Reno NV United States
Institute of Biotechnology Czech Academy of Sciences Vestec Czechia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024560
- 003
- CZ-PrNML
- 005
- 20240624144829.0
- 007
- ta
- 008
- 211006e20210615sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fncel.2021.678113 $2 doi
- 035 __
- $a (PubMed)34211371
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Elliott, Karen L $u Department of Biology, CLAS, The University of Iowa, Iowa City, IA, United States $u Department of Otolaryngology, CLAS, The University of Iowa, Iowa City, IA, United States
- 245 10
- $a Developmental Changes in Peripherin-eGFP Expression in Spiral Ganglion Neurons / $c KL. Elliott, J. Kersigo, JH. Lee, I. Jahan, G. Pavlinkova, B. Fritzsch, EN. Yamoah
- 520 9_
- $a The two types of spiral ganglion neurons (SGNs), types I and II, innervate inner hair cells and outer hair cells, respectively, within the mammalian cochlea and send another process back to cochlear nuclei in the hindbrain. Studying these two neuronal types has been made easier with the identification of unique molecular markers. One of these markers, peripherin, was shown using antibodies to be present in all SGNs initially but becomes specific to type II SGNs during maturation. We used mice with fluorescently labeled peripherin (Prph-eGFP) to examine peripherin expression in SGNs during development and in aged mice. Using these mice, we confirm the initial expression of Prph-eGFP in both types I and II neurons and eventual restriction to only type II perikarya shortly after birth. However, while Prph-eGFP is uniquely expressed within type II cell bodies by P8, both types I and II peripheral and central processes continue to express Prph-eGFP for some time before becoming downregulated. Only at P30 was there selective type II Prph-eGFP expression in central but not peripheral processes. By 9 months, only the type II cell bodies and more distal central processes retain Prph-eGFP expression. Our results show that Prph-eGFP is a reliable marker for type II SGN cell bodies beyond P8; however, it is not generally a suitable marker for type II processes, except for central processes beyond P30. How the changes in Prph-eGFP expression relate to subsequent protein expression remains to be explored.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kersigo, Jennifer $u Department of Biology, CLAS, The University of Iowa, Iowa City, IA, United States $u Department of Otolaryngology, CLAS, The University of Iowa, Iowa City, IA, United States
- 700 1_
- $a Lee, Jeong Han $u Department of Physiology, School of Medicine, University of Nevada, Reno, Reno, NV, United States
- 700 1_
- $a Jahan, Israt $u Department of Biology, CLAS, The University of Iowa, Iowa City, IA, United States $u Department of Otolaryngology, CLAS, The University of Iowa, Iowa City, IA, United States
- 700 1_
- $a Pavlínková, Gabriela, $u Institute of Biotechnology, Czech Academy of Sciences, Vestec, Czechia $d 1966- $7 xx0319150
- 700 1_
- $a Fritzsch, Bernd $u Department of Biology, CLAS, The University of Iowa, Iowa City, IA, United States $u Department of Otolaryngology, CLAS, The University of Iowa, Iowa City, IA, United States
- 700 1_
- $a Yamoah, Ebenezer N $u Department of Physiology, School of Medicine, University of Nevada, Reno, Reno, NV, United States
- 773 0_
- $w MED00163312 $t Frontiers in cellular neuroscience $x 1662-5102 $g Roč. 15 (20210615), s. 678113
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34211371 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20211006 $b ABA008
- 991 __
- $a 20240624144827 $b ABA008
- 999 __
- $a ind $b bmc $g 1708372 $s 1145057
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 15 $c - $d 678113 $e 20210615 $i 1662-5102 $m Frontiers in cellular neuroscience $n Front Cell Neurosci $x MED00163312
- LZP __
- $a Pubmed-20211006